|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12P 21/08 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2812443 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13746964.9 |
| Date of filing the European patent application | 2013-02-06 | |
| (97) | Date of publication of the European application | 2014-12-17 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-29 |
| (46) | Date of publication of the claims translation | 2019-09-10 |
| (86) | Number | PCT/US2013/024995 |
| Date | 2013-02-06 |
| (87) | Number | WO 2013/119714 |
| Date | 2013-08-15 |
| (30) | Number | Date | Country code |
| 201261595216 P | 2012-02-06 | US | |
| 201261659752 P | 2012-06-14 | US |
| (72) |
ECKELMAN, Brendan, US
TIMMER, John, US
RAZAI, Amir, US
DEVERAUX, Quinn, US
JONES, Kyle, US
NGUY, Peter, L., US
|
| (73) |
Inhibrx Biosciences, Inc. ,
11025 N. Torrey Pines Road, Suite 140, La Jolla, CA 92037,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | CD47 antikūnai ir jų panaudojimo būdai |
| CD47 ANTIBODIES AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2024-01-03 | 12 | 289.00 EUR |
| 2025-02-06 |